Stock A222040 COSMAX NBT, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Cosmax Nbt, Inc.

Equities

A222040

KR7222040008

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 02/05/2024 BST 		5-day change 1st Jan Change
4,460 KRW -0.34% Intraday chart for Cosmax Nbt, Inc. +3.48% -30.53%
2023 Tranche Update on Cosmax Nbt, Inc.'s Equity Buyback Plan announced on June 27, 2023. CI
2023 Tranche Update on Cosmax Nbt, Inc.'s Equity Buyback Plan announced on June 27, 2023. CI

Strengths

  • Its low valuation, with P/E ratio at 5.97 and 4.41 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
  • The company is one of the most undervalued, with an "enterprise value to sales" ratio at 245.7 for the 2024 fiscal year.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • The company does not generate enough profits, which is an alarming weak point.
  • The group shows a rather high level of debt in proportion to its EBITDA.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
  • The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Sector: Food Processing

1st Jan change Capi. Investor Rating ESG Refinitiv
COSMAX NBT, INC. Stock Cosmax Nbt, Inc.
-30.53% 67.67M -
ZHEJIANG NHU COMPANY LTD. Stock Zhejiang NHU Company Ltd.
+16.16% 8.15B
D+
BELLRING BRANDS, INC. Stock BellRing Brands, Inc.
+3.59% 7.52B
C-
CSPC INNOVATION PHARMACEUTICAL CO., LTD. Stock CSPC Innovation Pharmaceutical Co., Ltd.
+11.45% 6.65B -
THE SIMPLY GOOD FOODS COMPANY Stock The Simply Good Foods Company
-7.02% 3.73B
B-
BYHEALTH CO., LTD Stock Byhealth Co., Ltd
-6.11% 3.72B
D
XIAMEN KINGDOMWAY GROUP COMPANY Stock Xiamen Kingdomway Group Company
+1.10% 1.31B - -
SIRIO PHARMA CO., LTD. Stock Sirio Pharma Co., Ltd.
+15.20% 972M -
HERBALIFE LTD. Stock Herbalife Ltd.
-36.30% 958M
B+
USANA HEALTH SCIENCES, INC. Stock USANA Health Sciences, Inc.
-15.78% 876M
C+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
Earnings quality
  1. Stock Market
  2. Equities
  3. A222040 Stock
  4. Ratings Cosmax Nbt, Inc.